Britannia Pharmaceuticals Ltd - Strategic SWOT Analysis Review

November 2021 | 17 pages | ID: B59503D807BEN
GlobalData

Abstracts

Britannia Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Britannia Pharmaceuticals Ltd (BPL), a subsidiary of STADA Arzneimittel AG, is a pharmaceutical company, which offers orphan drugs (drugs for rare diseases affecting small patient populations). The company develops and markets products in the area of Parkinson's disease, and mental health disorders. It is also focuses on evaluating opportunities for the neurology market and exploring ways to bring new products into the market. One of its core product include apomorphine hydrochloride, among others. BPL is headquartered in Reading, Berkshire, the UK.

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Britannia Pharmaceuticals Ltd - Key Facts
Britannia Pharmaceuticals Ltd - Key Employees
Britannia Pharmaceuticals Ltd - Major Products and Services
Britannia Pharmaceuticals Ltd - History
Britannia Pharmaceuticals Ltd - Locations And Subsidiaries
Head Office

SECTION 2 – COMPANY ANALYSIS

Company Overview
Britannia Pharmaceuticals Ltd - Business Description
Britannia Pharmaceuticals Ltd - SWOT Analysis
SWOT Analysis - Overview
Britannia Pharmaceuticals Ltd - Strengths
Britannia Pharmaceuticals Ltd - Weaknesses
Britannia Pharmaceuticals Ltd - Opportunities
Britannia Pharmaceuticals Ltd - Threats
Britannia Pharmaceuticals Ltd - Key Competitors

SECTION 3 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Britannia Pharmaceuticals Ltd, Key Facts
Britannia Pharmaceuticals Ltd, Key Employees
Britannia Pharmaceuticals Ltd, Major Products and Services
Britannia Pharmaceuticals Ltd, History
Britannia Pharmaceuticals Ltd, Key Competitors